Literature DB >> 23377550

Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.

Jana Blaževski1, Filip Petković, Miljana Momčilović, Reinhard Paschke, Goran N Kaluđerović, Marija Mostarica Stojković, Djordje Miljković.   

Abstract

AIM: To investigate the influences of betulinic acid (BA), a triterpenoid isolated from birch bark, on neuroinflammatory mediators involved in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis in vitro.
METHODS: Encephalitogenic T cells were prepared from draining lymph nodes and spinal cords of Dark Agouti rats 8 to 10 d after immunization with myelin basic protein (MBP) and complete Freund's adjuvant. Macrophages were isolated from the peritoneal cavity of adult untreated rats. Astrocytes were isolated from neonatal rat brains. The cells were cultured and then treated with different agents. IFN-γ, IL-17, iNOS and CXCL12 mRNA levels in the cells were analyzed with RT-PCR. iNOS and CXCL12 protein levels were detected using immunoblot. NO and ROS generation was measured using Griess reaction and flow cytometry, respectively.
RESULTS: In encephalitogenic T cells stimulated with MBP (10 μg/mL), addition of BA inhibited IL-17 and IFN-γ production in a dose-dependent manner. The estimated IC(50) values for IL-17 and IFN γ were 11.2 and 63.8 μmol/L, respectively. When the macrophages were stimulated with LPS (10 ng/mL), addition of BA (50 μmol/L) significantly increased ROS generation, and suppressed NO generation. The astrocytes were stimulated with ConASn containing numerous inflammatory mediators, which mimicked the inflammatory milieu within CNS; addition of BA (50 μmol/L) significantly increased ROS generation, and blocked ConASn-induced increases in iNOS and CXCL12 mRNA levels, but did not affect iNOS and CXCL12 protein levels. Importantly, in both the macrophages and astrocytes, addition of BA (50 μmol/L) inhibited lipid peroxidation.
CONCLUSION: Besides inhibiting encephalitogenic T cell cytokines and reducing NO generation, BA induces tissue-damaging ROS generation within CNS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377550      PMCID: PMC4002495          DOI: 10.1038/aps.2012.181

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  38 in total

1.  Malondialdehyde determination as index of lipid peroxidation.

Authors:  H H Draper; M Hadley
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Betulinic acid and its derivatives: a review on their biological properties.

Authors:  Perumal Yogeeswari; Dharmarajan Sriram
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.

Authors:  D Matusevicius; P Kivisäkk; B He; N Kostulas; V Ozenci; S Fredrikson; H Link
Journal:  Mult Scler       Date:  1999-04       Impact factor: 6.312

4.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination.

Authors:  A H Cross; P T Manning; M K Stern; T P Misko
Journal:  J Neuroimmunol       Date:  1997-12       Impact factor: 3.478

5.  Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.

Authors:  Y Okuda; S Sakoda; H Fujimura; T Yanagihara
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

6.  Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2.

Authors:  T P Misko; J L Trotter; A H Cross
Journal:  J Neuroimmunol       Date:  1995-09       Impact factor: 3.478

7.  Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis.

Authors:  J Link; M Söderström; T Olsson; B Höjeberg; A Ljungdahl; H Link
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

8.  Exacerbations of multiple sclerosis in patients treated with gamma interferon.

Authors:  H S Panitch; R L Hirsch; A S Haley; K P Johnson
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

9.  Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes.

Authors:  S J Hewett; T P Misko; R M Keeling; M M Behrens; D W Choi; A H Cross
Journal:  J Neuroimmunol       Date:  1996-02       Impact factor: 3.478

Review 10.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

View more
  7 in total

1.  Betulinic Acid Induces Apoptosis in Differentiated PC12 Cells Via ROS-Mediated Mitochondrial Pathway.

Authors:  Xi Wang; Xiaocheng Lu; Ronglan Zhu; Kaixin Zhang; Shuai Li; Zhongjun Chen; Lixin Li
Journal:  Neurochem Res       Date:  2017-01-25       Impact factor: 3.996

2.  Evaluation of betulinic acid effects on pain, memory, anxiety, catalepsy, and oxidative stress in animal model of Parkinson's disease.

Authors:  M Abrishamdar; Yaghoob Farbood; A Sarkaki; M Rashno; M Badavi
Journal:  Metab Brain Dis       Date:  2022-06-16       Impact factor: 3.584

Review 3.  Anti-Inflammatory Activities of Betulinic Acid: A Review.

Authors:  José Fernando Oliveira-Costa; Cássio Santana Meira; Maria Vitória Gomes das Neves; Bruna Padilha Zurita Claro Dos Reis; Milena Botelho Pereira Soares
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

4.  Neonatal Rat Glia Cultured in Physiological Normoxia for Modeling Neuropathological Conditions In Vitro.

Authors:  Justyna Gargas; Justyna Janowska; Karolina Ziabska; Malgorzata Ziemka-Nalecz; Joanna Sypecka
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

5.  Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy.

Authors:  Xiao-yin Wang; Shu-yong Zhang; Jing Li; Hua-nan Liu; Xin Xie; Fa-jun Nan
Journal:  Acta Pharmacol Sin       Date:  2014-10-06       Impact factor: 6.150

6.  Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay.

Authors:  Shih-Hsiang Lo; Kai-Chung Cheng; Ying-Xiao Li; Chin-Hong Chang; Juei-Tang Cheng; Kung-Shing Lee
Journal:  Drug Des Devel Ther       Date:  2016-08-22       Impact factor: 4.162

7.  Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2).

Authors:  Mohammad Firoz Khan; Nusrat Nahar; Ridwan Bin Rashid; Akhtaruzzaman Chowdhury; Mohammad A Rashid
Journal:  BMC Complement Altern Med       Date:  2018-02-02       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.